Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,977 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,375
Recruiting: 744
Ph III recruiting: 79
Growth YoY: +22%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.1%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 1–50 of 291 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06496256	Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial	recruiting	N/A	84	Palette Life Sciences, Inc.INDUSTRY	2	Sep 28, 2026	clinicaltrials
NCT07126548	A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men	recruiting	N/A	200	Mayo ClinicOTHER	1	Sep 25, 2026	clinicaltrials
NCT07339943